A randomized, open-label, multicenter trial comparing once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: Improved physical functioning in the ACTION trial
Abstract
Keywords
Full Text:
PDFReferences
Rauck RL, Bookbinder SA, Bunker TR, et al.: The ACTION Study: A randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA®) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin®) for the treatment of chronic, moderate to severe low back pain. J OpioidManag. 2006; 2(3): 155-166.
Rauck RL, Bookbinder SA, Bunker TR, et al.: A randomized, open-label study of once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: The extension phase of the ACTION trial. J OpioidManag. 2006; 2(6): 325-333.
Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34(3): 220-233.
Lerner D, Amick BC, Rogers WH, et al.: The Work Limitations Questionnaire. Med Care. 2001; 39(1): 72-85.
Luo X, Pietrobon R, Sun SX, et al.: Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine. 2004; 29(1): 79-86.
Allan DB, Waddell G: A historical perspective on low back pain and disability. Acta Orthop Scand. 1989; 60(Suppl 234): 1-23.
Moulin DE: Systemic drug treatment for chronic musculoskeletal pain. Clin J Pain. 2001; 17(4 Suppl): S86-S93.
Moulin DE, Iezzi A, Amireh R, et al.: Randomised trial of oral mor-phine for chronic non-cancer pain. Lancet. 1996; 347(8995): 143-147.
McCarberg BH, Barkin RL: Long-acting opioids for chronic pain: Pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther. 2001; 8(3): 181-186.
Peloso PM, Bellamy N, Bensen W, et al.: Double-blind randomized placebo-controlled trial of controlled-release codeine in the treatment of osteoarthritis of the hip and knee. J Rheumatol. 2000; 27: 764-771.
Dworkin RH, Turk DC, Farrar JT, et al.: Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005; 113(1-2): 9-19.
Caldwell JR, Rapoport RJ, Davis JC, et al.: Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: Results from a randomized, placebocontrolled, double-blind trial and an open-label extension trial. J Pain Symptom Manage. 2002; 23(4): 278-291.
Adams EH, Chwiecko P, Ace-Wagoner Y, et al.: A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions—The ACCPT Study. Pain Pract. 2006; 6(4): 254-264.
Nicholson B, Ross E, Sasaki J, et al.: Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain. Curr Med Res Op. 2006; 22(8): 1503-1514.
DOI: https://doi.org/10.5055/jom.2007.0037
Refbacks
- There are currently no refbacks.